Hemoral 450 mg+50 mg (Tablet)
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Diosmin hesperidin |
| Company | Aristopharma ltd |
Indications
- Acute hemorrhoidal attacks
- Chronic hemorrhoidal disease
- Organic and functional chronic venous insufficiency of the lower limbs with symptoms: heavy legs, pain, nocturnal cramps
Composition
- Diosmin micronised BP 450 mg
- Hesperidin micronised INN 50 mg
- Diosmin micronised BP 900 mg
- Hesperidin micronised USP 100 mg
Pharmacology
- Phlebotonic drug and vascular protecting agent
- Reinforces venous tone
- Decreases venous capacitance, distensibility, and emptying time
- Protects microcirculation
- Combats venous inflammation
- Normalizes capillary permeability
- Strengthens capillary resistance
- Acts on the lymphatic system
- Improves lymphatic drainage
Dosage
- Diosmin 450 mg & Hesperidin 50 mg:
- Acute hemorrhoidal attacks: 3 tablets twice daily for the first 4 days, then 2 tablets twice daily for three days and if required 1 tablet twice daily as a maintenance dosage
- Chronic hemorrhoids: 1 tablet twice daily
- Chronic venous insufficiency: 1 tablet twice daily initially for seven days. Duration may be increased depending on severity
- Diosmin 900 mg & Hesperidin 100 mg:
- Acute Hemorrhoid: 1 tablet thrice daily for first 4 days, followed by 1 tablet twice daily for 3 days & then 1 tablet once daily as maintenance dose
- Relapse of Internal Hemorrhoid & Chronic Hemorrhoid: 1 tablet once daily for 3 months
- Chronic venous insufficiency: 1 tablet once daily for 2-6 months
- Leg Wounds: 1 tablet once daily for 2 months
Administration
Tablet should be taken at meal times
Interaction
No evidence of drug incompatibility (drug interaction) reported in clinical trials
Contraindications
Contraindicated for anyone having hypersensitivity to any ingredient in the product
Side Effects
Some cases of routine gastric disorders and neurovegetative disorders reported, discontinuation of treatment not required
Pregnancy & Lactation
No harmful effect reported in human beings, breastfeeding not recommended during treatment
Precautions & Warnings
- If hemorrhoidal symptoms do not disappear within 15 days, patient should consult a doctor
- Not recommended for patients with a history of cancer
- No evidence of carcinogenicity or mutagenicity reported
Therapeutic Class
Phlebotonic & Vascular protecting preparation
Storage Conditions
Keep below 30°C temperature, away from light & moisture, keep out of the reach of children